Fortrea Holdings (FTRE) Change in Cash (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Change in Cash came in at $21.1 million in Q2 2026, up 203.43% YoY from $7.0 million in Q2 2025, and up 177.86% on a QoQ basis from -$27.1 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Change in Cash (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Change in Cash data on file, last reported at $21.1 million in Q2 2026.
- Quarterly Change in Cash rose 203.43% year-over-year to $21.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $87.4 million (up 294.22% YoY) and the FY2025 annual result came in at $56.1 million, up 466.67% from the prior year.
- Change in Cash grew to $21.1 million in Q2 2026, from -$27.1 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $50.1 million in Q3 2025 to a low of -$27.1 million in Q1 2026.
- A 5-year average of $4.6 million and a median of $3.8 million in 2022 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 459.14% in 2024, down 309.8% in 2024.
- Tracing FTRE's Change in Cash over 5 years: stood at $2.9 million in 2022, then jumped by 65.52% to $4.8 million in 2023, then soared by 175.0% to $13.2 million in 2024, then surged by 228.03% to $43.3 million in 2025, then slumped by 51.27% to $21.1 million in 2026.
- The last three Change in Cash figures came in at $21.1 million (Q2 2026), -$27.1 million (Q1 2026), and $43.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Fortrea Holdings | 1.73 Bn | 1.56 Bn | 139.20 Mn | 21.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.10 Mn |
| Mar 31, 2026 | -27.10 Mn |
| Dec 31, 2025 | 43.30 Mn |
| Sep 30, 2025 | 50.10 Mn |
| Jun 30, 2025 | -20.40 Mn |
| Mar 31, 2025 | -16.90 Mn |
| Dec 31, 2024 | 13.20 Mn |
| Sep 30, 2024 | -20.90 Mn |
| Jun 30, 2024 | 33.40 Mn |
| Mar 31, 2024 | -15.80 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -9.30 Mn |
| Mar 31, 2023 | 7.80 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Sep 30, 2022 | 12.00 Mn |